StockData
Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc. (RLMD) dividend history

RLMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$4.21+0.05 (+1.20%)

Close on Nov 13, 2026Market cap $449.08MP/E –Yield –

Dividends

Relmada Therapeutics has not reported a dividend

No dividend per share appears in Relmada Therapeutics's annual filings since fiscal 2011.

See a number that looks wrong?